The diterpenes sinupol and sinulacetate exhibit good inhibitory activity against protein tyrosine phosphatase 1B (PTP1B), which in turn is a potential drug target for the treatment of type II diabetes and obesity (Ye et al., 2018). The gene discussed is PTPN1; the disease is obesity due to melanocortin 4 receptor deficiency.